| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| N,N'-二丁基哌嗪-1,4-二硫代甲酰胺 | N,N'-dibutylpiperazine-1,4-dithiocarboxamide | 80490-80-8 | C14H28N4S2 |
| N,N'-二[2-(1-哌嗪基)乙基]乙烷二硫代酰胺 | N,N'-bis-(2-piperazinoethyl)-dithiooxamide | 17551-76-7 | C14H28N6S2 |
| N,5-二甲基-2-(哌嗪-1-基)噻吩并[2,3-d]嘧啶-4-胺二盐酸 | N,5-dimethyl-2-piperazin-1-ylthieno[2,3-d]pyrimidin-4-amine;hydron;dichloride | —— | C12H19Cl2N5S |
| N,4-二苯基哌嗪-1-甲酰胺 | N,4-diphenylpiperazine-1-carboxamide | 4791-20-2 | C17H19N3O |
| N,4-二甲基-N-(4-硝基苯基)-1-哌嗪乙酰胺 | N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide | 1139453-98-7 | C14H20N4O3 |
| N,4-二甲基-1-哌嗪硫代甲酰胺 | N,4-dimethylpiperazine-1-carbothioamide | 64574-95-4 | C7H15N3S |
| N,4-二甲基-1-哌嗪甲酰胺 | 1-Methyl-4-methylcarbamoyl-piperazin | 89856-17-7 | C7H15N3O |
| N,4-二甲基-1-哌嗪亚胺代甲酰肼 | N,N'-Dimethylpiperazine-1-carboximidohydrazide | 214056-00-5 | C7H17N5 |
| N,4-二甲基-1-哌嗪丙胺 | N-methyl-3-(4-methylpiperazin-1-yl)propan-1-amine | 864244-66-6 | C9H21N3 |
| N,3-二甲基-4-(哌嗪-1-基)苯甲酰胺 | N,3-dimethyl-4-(piperazin-1-yl)benzamide | 1018269-12-9 | C13H19N3O |
| N'-[(5-硝基呋喃-2-基)亚甲基]-4-苯乙基-1-哌嗪乙酰肼 | 5-Nitro-furfural-<(4-phenaethyl-piperazino)-acetylhydrazon> | 24637-24-9 | C19H23N5O4 |
| N'-[(5-硝基呋喃-2-基)亚甲基]-4-苄基-1-哌嗪乙酰肼 | 2-Furaldehyde, 5-nitro-, (4-benzylpiperazinylacetyl)hydrazone | 24637-23-8 | C18H21N5O4 |
| N'-[(5-硝基呋喃-2-基)亚甲基]-4-异丙基-1-哌嗪乙酰肼 | 2-Furaldehyde, 5-nitro-, (4-isopropylpiperazinylacetyl)hydrazone | 24637-21-6 | C14H21N5O4 |
| N'-[(5-硝基呋喃-2-基)亚甲基]-4-十二烷基-1-哌嗪乙酰肼 | 4-Dodecyl-1-piperazineacetic acid (5-nitrofurfurylidene)hydrazide | 24632-53-9 | C23H39N5O4 |
| N'-[(5-硝基呋喃-2-基)亚甲基]-4-乙酰基-1-哌嗪乙酰肼 | 5-Nitro-furfural-<(4-acetyl-piperazino)-acetylhydrazon> | 24632-58-4 | C13H17N5O5 |
| N'-[(5-硝基呋喃-2-基)亚甲基]-4-丁基-1-哌嗪乙酰肼 | 2-Furaldehyde, 5-nitro-, (4-butylpiperazinylacetyl)hydrazone | 24637-22-7 | C15H23N5O4 |
| N'-[(5-硝基呋喃-2-基)亚甲基]-4-[(二乙基氨基)羰基]-1-哌嗪乙酰肼 | 5-Nitro-furfural-<(4-diaethylcarbamoyl-piperazino)-acetylhydrazon> | 24632-55-1 | C16H24N6O5 |
| N'-[(5-硝基呋喃-2-基)亚甲基]-4-(2-羟基乙基)-1-哌嗪乙酰肼 | 2-Furaldehyde, 5-nitro-, (4-(2-hydroxyethyl)piperazinylacetyl)hydrazone | 24632-59-5 | C13H19N5O5 |
| N'-[(3E)-5-氯-1-{[4-(4-硝基苯基)哌嗪-1-基]甲基}-2-羰基-1,2-二氢-3H-吲哚-3-亚基]-3,5-二硝基苯并酰肼 | Benzoic acid, 3,5-dinitro-, (5-chloro-1,2-dihydro-1-((4-(4-nitrophenyl)-1-piperazinyl)methyl)-2-oxo-3H-indol-3-ylidene)hydrazide | 100757-09-3 | C26H21ClN8O8 |
| N'-(5-氯-2-氧代-2H-吲哚-3-基)-2-(4-甲基-1-哌嗪基)乙酰肼二盐酸盐 | 1-Piperazineacetic acid, 4-methyl-, (5-chloro-2-oxo-3-indolinylidene)hydrazide, dihydrochloride, hydrate, (Z)- | 86873-24-7 | C15H20Cl3N5O2 |
| N'-(5,7-二氯-2-氧代-2H-吲哚-3-基)-2-(4-甲基-1-哌嗪基)乙酰肼 | 1-Piperazineacetic acid, 4-methyl-, (5,7-dichloro-2-oxo-3-indolinylidene)hydrazide, (Z)- | 86873-26-9 | C15H17Cl2N5O2 |
| N'-(3,4-二氯苯基)-4-(2-甲氧基苯基)哌嗪-1-甲脒二盐酸盐 | N'-(3,4-dichlorophenyl)-4-(2-methoxyphenyl)piperazine-1-carboximidamide;hydron;dichloride | —— | C18H22Cl4N4O |
| N'-(2-氧代-2H-吲哚-3-基)-2-(1-哌嗪基)乙酰肼二盐酸盐 | 1-Piperazineacetic acid, (2-oxo-3-indolinylidene)hydrazide, dihydrochloride, sesquihydrate, (Z)- | 86873-20-3 | C14H19Cl2N5O2 |
| MK 212盐酸盐 | 6-chloro-2-(1-piperazinyl)pyrazine | 64022-27-1 | C8H11ClN4 |
| LP-12盐酸盐 | LP 12 hydrochloride | 1185136-22-4 | C32H40ClN3O |
| LEE011琥珀酸盐 | ribociclib succinate | 1374639-75-4 | C4H6O4*C23H30N8O |
| LB-100抑制剂 | LB-100 | 1026680-07-8 | C13H20N2O4 |
| L-苯丙氨酸,2,5-二甲氧基- | 3-(Pyridin-3-YL)-3,8-diazabicyclo[3.2.1]octane | 286944-38-5 | C11H15N3 |
| L-778123二盐酸盐 | L-778123 Dihydrochloride | 183499-56-1 | C22H22Cl3N5O |
| L-750667三盐酸盐 | L-750,667 trihydrochloride | 1021868-80-3 | C18H22Cl3IN4 |
| KRasG12C抑制剂4 | KRas G12C inhibitor 4 | 2206736-07-2 | C33H38ClN7O2 |
| I型P21激活激酶(PAK)抑制剂(FRAX597) | FRAX597 | 1286739-19-2 | C29H28ClN7OS |
| INTEPIRDINE中间体 | tert-butyl 4-[3-(phenylsulfonyl)quinolin-8-yl]piperazine-1-carboxylate | 607743-10-2 | C24H27N3O4S |
| HSD抑制剂23 | N-[(E)-5-hydroxy-2-adamantyl]-2-methyl-2-{4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}propanamide | 868604-75-5 | C24H33F3N4O2 |
| HOECHST33258类似物5,BR | 2'-(naphth-2-yl)-5-(4-methylpiperazinyl)-2,5'-bi-1H-benzimidazole | 23491-55-6 | C29H26N6 |
| FGFR抑制剂(NVP-BGJ398) | BGJ398 | 872511-34-7 | C26H31Cl2N7O3 |
| EZH2甲基转移酶抑制剂(GSK126) | GSK-126 | 1346574-57-9 | C31H38N6O2 |
| DL-乳酸伏硫西汀 | 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine DL-lactate | 1253056-29-9 | C3H6O3*C18H22N2S |
| CO-1686氢溴酸盐 | Rociletinib hydrobromide | 1446700-26-0 | 2BrH*C27H28F3N7O3 |
| CO-1686中间体三 | 1-(4-(4-amino-3-methoxyphenyl)piperazin-1-yl)ethanone | 1021426-42-5 | C13H19N3O2 |
| CERDULATINIB盐酸盐 | cerdulatinib hydrochloride | 1369761-01-2 | C20H27N7O3S*ClH |
| CCT 129202; 2-[4-[6-氯-2-(4-二甲基氨基苯基)-3H-咪唑并[4,5-b]吡啶-7-基]哌嗪-1-基]-N-(噻唑-2-基)乙酰胺 | CCT 129202 | 942947-93-5 | C23H25ClN8OS |
| Bitopertin中间体 | 1-(3-fluoro-5-(trifluoromethyl)pyridin-2-yl)piperazine | 845616-81-1 | C10H11F4N3 |
| BOC-2-甲基哌嗪甲酰氯 | tert-butyl (R)-4-(chlorocarbonyl)-3-methylpiperazine-1-carboxylate | 438050-54-5 | C11H19ClN2O3 |
| BMS 554417; 4-[2-[4-[[(2S)-2-(3-氯苯基)-2-羟基乙基]氨基]-1,2-二氢-2-氧代-3-吡啶基]-7-甲基-1H-苯并咪唑-5-基]-1-哌嗪丙腈 | BMS-554417 | 468741-42-6 | C28H30ClN7O2 |
| 氨苄西林杂质G | (3R,6R)-3,6-bis(phenyl)piperazine-2,5-dione | 31485-02-6 | C16H14N2O2 |
| ABT-199中间体 | 4-(2-bromo-5,5-dimethyl-cyclohex-1-enylmethyl)-piperazine-1-carboxylic acid tert-butyl ester | 1229247-71-5 | C18H31BrN2O2 |
| 9H-嘌呤,8-甲氧基-9-甲基-6-(1-哌嗪基)- | 8-Methoxy-9-methyl-6-(1-piperazinyl)purine | 121370-86-3 | C11H16N6O |
| 9-苯基-8-(4-苯基哌嗪-1-基)双环[3.3.1]壬烷-9-醇 | 2-(4-Phenyl-1-piperazinyl)-9-phenylbicyclo<3.3.1>nonan-9-ol | 30297-79-1 | C25H32N2O |
| 9-甲基-3,9-二氮杂双环[3.3.1]壬烷-7-醇 | 9-Methyl-3,9-diazabicyclo[3.3.1]nonan-6-OL | 3181-47-3 | C8H16N2O |